Cerus Corp (CERS)
1.63
-0.13
(-7.39%)
USD |
NASDAQ |
May 03, 16:00
1.63
0.00 (0.00%)
After-Hours: 20:00
Cerus SG&A Expense (Quarterly): 17.27M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 17.27M |
September 30, 2023 | 16.16M |
June 30, 2023 | 20.54M |
March 31, 2023 | 21.55M |
December 31, 2022 | 23.16M |
September 30, 2022 | 19.91M |
June 30, 2022 | 19.53M |
March 31, 2022 | 20.74M |
December 31, 2021 | 22.00M |
September 30, 2021 | 20.36M |
June 30, 2021 | 19.76M |
March 31, 2021 | 19.17M |
December 31, 2020 | 18.69M |
September 30, 2020 | 16.30M |
June 30, 2020 | 16.11M |
March 31, 2020 | 15.91M |
December 31, 2019 | 17.16M |
September 30, 2019 | 16.14M |
June 30, 2019 | 16.74M |
March 31, 2019 | 16.16M |
December 31, 2018 | 14.83M |
September 30, 2018 | 13.96M |
June 30, 2018 | 14.44M |
March 31, 2018 | 13.61M |
December 31, 2017 | 12.56M |
Date | Value |
---|---|
September 30, 2017 | 12.23M |
June 30, 2017 | 14.14M |
March 31, 2017 | 13.68M |
December 31, 2016 | 12.64M |
September 30, 2016 | 12.16M |
June 30, 2016 | 12.41M |
March 31, 2016 | 11.75M |
December 31, 2015 | 11.28M |
September 30, 2015 | 10.93M |
June 30, 2015 | 12.06M |
March 31, 2015 | 11.72M |
December 31, 2014 | 10.69M |
September 30, 2014 | 8.724M |
June 30, 2014 | 10.08M |
March 31, 2014 | 8.236M |
December 31, 2013 | 7.43M |
September 30, 2013 | 7.728M |
June 30, 2013 | 7.954M |
March 31, 2013 | 6.853M |
December 31, 2012 | 6.794M |
September 30, 2012 | 6.219M |
June 30, 2012 | 6.686M |
March 31, 2012 | 5.966M |
December 31, 2011 | 5.938M |
September 30, 2011 | 5.38M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
15.91M
Minimum
Mar 2020
23.16M
Maximum
Dec 2022
18.80M
Average
19.17M
Median
Mar 2021
SG&A Expense (Quarterly) Benchmarks
Perspective Therapeutics Inc | 1.694M |
Retractable Technologies Inc | 4.158M |
Xtant Medical Holdings Inc | 20.45M |
Asensus Surgical Inc | 7.773M |
Catheter Precision Inc | 2.729M |